泰格医药

- 300347

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
泰格医药(300347) 利润表
单位:万元
报表日期2025-12-312025-09-302025-06-302025-03-312024-12-31
一、营业总收入683,280.06502,586.83325,044.43156,414.36660,312.02
营业收入683,280.06502,586.83325,044.43156,414.36660,312.02
二、营业总成本631,264.53455,952.75294,226.31142,141.80561,004.80
营业成本495,960.63356,025.20227,246.58109,438.27436,110.69
营业税金及附加3,492.902,558.571,631.47702.812,803.82
销售费用23,465.8117,544.9810,791.024,869.5920,760.78
管理费用72,590.6453,084.0535,528.5018,048.7173,684.25
财务费用9,990.187,615.956,328.243,174.843,806.70
研发费用25,764.3619,124.0012,700.495,907.5823,838.55
资产减值损失----------
公允价值变动收益4,225.6332,319.14-8,964.40-2,239.18-50,168.82
投资收益43,381.5944,022.0823,300.082,530.9716,664.22
其中:对联营企业和合营企业的投资收益19,850.68--16,638.56--3,127.09
汇兑收益----------
三、营业利润100,942.00122,900.9544,425.7914,450.4466,441.90
加:营业外收入223.8780.9149.7415.95509.01
减:营业外支出844.36703.78206.59103.86504.76
其中:非流动资产处置损失----------
四、利润总额100,321.51122,278.0844,268.9314,362.5366,446.15
减:所得税费用19,815.8913,109.967,986.103,364.4521,663.02
五、净利润80,505.62109,168.1236,282.8310,998.0844,783.13
归属于母公司所有者的净利润88,789.01102,043.4238,333.7116,546.8740,514.35
少数股东损益-8,283.397,124.70-2,050.88-5,548.794,268.78
六、每股收益
基本每股收益(元/股)1.04001.19000.45000.19000.4700
稀释每股收益(元/股)1.04001.19000.45000.19000.4700
七、其他综合收益-5,365.31964.644,898.32532.98-3,036.75
八、综合收益总额75,140.30110,132.7641,181.1511,531.0641,746.38
归属于母公司所有者的综合收益总额84,586.29102,920.4642,018.2717,140.8040,070.49
归属于少数股东的综合收益总额-9,445.997,212.30-837.12-5,609.741,675.89
下载全部历史数据到excel中 返回页顶